Get the Weekly Intelligence Brief — top committee picks every Sunday.
CNC · NYSE · STOCK

Centene (CNC) Stock Analysis

Healthcare Updated August 24, 2026
$65.64
52W $28.24 – $69.36
60/100
$32.12B
-6.3
1.10
AI Committee Verdict
Buy
60/100
Conviction: Moderate · 60% agreement · 5 analysts
+1.3%
-2.4%
0.54:1
Moderate
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is CNC Bullish or Bearish?

Bullish. Innellis AI committee rates Centene Corporation (CNC) Buy with a composite score of 60/100 , based on 5 analysts with 60% agreement. Last updated August 24, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +14.53 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -5.47 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee sees neither a compelling opportunity nor a clear risk at this stage. Conditions remain neutral — patience is warranted.

Bull & Bear Case

Bull Case
  • Price-to-book of 1.0x is a discount to asset value — Value
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Price structure making higher highs and higher lows — Technical
  • News sentiment is positive (+0.20 across 41 articles, 14d) — News
Bear Case
  • ROE of only -24.0% -- cheap may mean cheap for a reason — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 24, 2026
Overall Committee Score
60/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 34%
of 192 Healthcare peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Price-to-book of 1.0x is a discount to asset value
− ROE of only -24.0% -- cheap may mean cheap for a reason
Growth Analyst bullish
60 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 41 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3069.37)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 60.5 to 60.5.

Comparing 2026-08-23 to 2026-08-24 (1 day apart).

Technical Analysis

RSI (14)
49.5
Neutral
MACD Histogram
-0.110
Bearish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Mixed
Support
$63.49
Resistance
$65.86
Bollinger %B
0.55
Inside Bands
Price vs Moving Averages
EMA 9
$65.10 Above
EMA 21
$65.06 Above
EMA 50
$63.49 Above
EMA 200
$53.26 Above

Fundamental Analysis

Valuation
100
Growth
75
Profitability
0
Financial Health
59
Cash Flow
70
Valuation
P/E Ratio -6.3×
P/B Ratio 1.42×
PEG Ratio 0.02
Dividend Yield 0.00%
52W High $69.36
52W Low $28.24
Quality & Growth
ROE -3344.4%
ROA -859.2%
Gross Margin 1612.5%
Operating Margin -281.8%
Revenue Growth YoY
Debt / Equity 0.71
AI Fundamental Assessment
P/E ratio of -6.3 (inexpensive relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -33.4%; Return on assets of -8.6%; Net margin of -2.6%; Gross margin of 16.1%; Current ratio of 1.15 (tight short-term liquidity); Debt-to-equity of 0.71; Free cash flow per share is positive (18.16); Most recent quarter beat estimates by 129.0%; 4 consecutive earnings beats; EPS growth decelerating (+383.2% -> -25.5% QoQ); Average YoY EPS growth of 1668.8%; Analyst estimates rising over recent quarters
Get the Full CNC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime